Who has invested in InterVenn?

SoftBank are named among the investors backing InterVenn.

InterVenn Funding: $279M Raised, Series C (2024)

InterVenn funding overview

InterVenn is a Biotech company based in San Francisco, California. InterVenn has raised $279M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C announced in January 2024. The round record for InterVenn runs through 2024; nothing later has been disclosed. Investors on record include SoftBank.

InterVenn at a glance

Total raised: $279M
Latest round: Series C
Latest round date: January 2024
Industry: Biotech
Headquarters: San Francisco, California
Notable investors: SoftBank

Frequently asked about InterVenn funding

How much has InterVenn raised?: InterVenn has raised $279M in total disclosed funding across the rounds on record.
Who has invested in InterVenn?: SoftBank are named among the investors backing InterVenn.
What was the latest InterVenn funding round?: The most recent disclosed round is a Series C, announced in January 2024.
Where is InterVenn based?: InterVenn is based in San Francisco, California.
What sector does InterVenn operate in?: InterVenn is tracked under Biotech from San Francisco, California, with $279M in disclosed funding.
When did InterVenn last raise?: The last disclosed InterVenn round closed in January 2024 at Series C.

Every InterVenn figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in San Francisco at a similar stage.

InterVenn Funding: $279M Raised, Series C (2024)

InterVenn funding overview

InterVenn at a glance

Frequently asked about InterVenn funding

Companies related to InterVenn (40)

Browse related funding lists (5)